The varicella vaccine. Clinical trials in immunocompromised individuals.

View Abstract

A review of the use of live attenuated varicella vaccine in immunocompromised children, particularly those with underlying leukemia in remission, is presented. Data concerning safety, immunogenicity, and efficacy of this vaccine in high-risk children are reviewed. The unique contributions toward our understanding of varicella vaccine, including spread of vaccine-type virus, incidence of zoster, and immune correlates provided by studies of immunocompromised patients are discussed. The importance of protecting high-risk children against severe varicella by the use of varicella vaccine is apparent.

Investigators
Abbreviation
Infect. Dis. Clin. North Am.
Publication Date
1999-11-30
Volume
10
Issue
3
Page Numbers
583-94
Pubmed ID
8856353
Medium
Print
Full Title
The varicella vaccine. Clinical trials in immunocompromised individuals.
Authors
Gershon AA, LaRussa P, Steinberg S